Associations of oral contraceptive use with serum lipids and lipoproteins in young women: The bogalusa heart study

Annals of Epidemiology

Volumn 7, Issue 8, 1997, Pages 561-567

  Greenlund, Kurt J ^a,b   Webber, Larry S ^a,c   Srinivasan, Sathanur ^a,b   Wattigney, Wendy ^a,b   Johnson, Carolyn ^a,b   Berenson, Gerald S ^a,b  

^a Tulane Center for Cardiovascular Health   (United States)

^b Dept of Community Health Sciences   (United States)

^c Tulane School of Public Health and Tropical Medicine   (United States)

Author keywords

Lipids; Lipoproteins; Oral contraceptives

Indexed keywords

LIPID; LIPOPROTEIN; ORAL CONTRACEPTIVE AGENT;

ADULT; ANALYTIC METHOD; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL OBSERVATION; CORONARY RISK; FEMALE; FOLLOW UP; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK FACTOR;

AMERICAS; BIOLOGY; BLACKS; CHOLESTEROL; CONTRACEPTION; CONTRACEPTIVE METHODS--SIDE EFFECTS; CORRELATION STUDIES; CULTURAL BACKGROUND; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; ETHNIC GROUPS; FAMILY PLANNING; LIPID METABOLIC EFFECTS; LIPIDS; LONGITUDINAL STUDIES; LOUISIANA; NORTH AMERICA; NORTHERN AMERICA; ORAL CONTRACEPTIVES, COMBINED--SIDE EFFECTS; ORAL CONTRACEPTIVES--SIDE EFFECTS; PHYSIOLOGY; POPULATION; POPULATION CHARACTERISTICS; RESEARCH METHODOLOGY; RESEARCH REPORT; STATISTICAL STUDIES; STUDIES; UNITED STATES; WHITES;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANALYSIS OF VARIANCE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CONTRACEPTIVES, ORAL, HORMONAL; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LONGITUDINAL STUDIES; LOUISIANA; RISK FACTORS; SMOKING; TRIGLYCERIDES;

EID: 0030834394     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(97)00119-1     Document Type: Article

References (27)

1. Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M. Cardiovascular disease in women. Circulation. 1993;88:1999-2009.
2. Barrett-Connor E. Estrogen and coronary heart disease. In: Pearson TA, Criqui MH, Luepker RV, Oberman A, Winston M, eds. Primer in Preventive Cardiology. Dallas, TX: American Heart Association; 1994:249-254.
3. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA. 1991;265:1861-1867.
4. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med. 1988;319:1313-1317.
5. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. Past use of oral contraceptives and cardiovascular disease: A meta-analysis in the context of the Nurses' Health Study. Am J Obstet Gynecol. 1990;163 (pt2):285-291.
6. Colditz GA. Oral contraceptive use and mortality during 12 years of follow-up: The Nurses' Health study. Ann Intern Med. 1994;120:821-826.
7. Slone D, Shapiro S, Kaufman DW, Rosenberg L, Miettinen OS, Stolley PD. Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. N Engl J Med. 1981;305:420-424.
8. LaRosa JC. The varying effects of progestins on lipid levels and cardiovascular disease. Am J Obstet Gynecol. 1988;158(pt2);1621-1629.
9. Flint PM, Lapane KL, Barbour MM, Derby CA, Carleton RA, Hume AL. Cardiovascular risk profiles of oral contraceptive users and nonusers: a population-based study. Prev Med. 1995;24:585-590.
10. Raitakari OT, Porkka KVK, Rasanen L, Viikari JSA. Relations of life-style with lipids, blood pressure and insulin in adolescents and young adults. The Cardiovascular Risk in Young Finns study. Atherosclerosis. 1994;111:237-246.
11. Vaziri SM, Evans JC, Larson MG, Wilson PWF. The impact of female hormone usage on the lipid profile: The Framingham Offspring Study. Arch Intern Med. 1993;153:2200-2206.
12. Croft JB, Freedman DS, Cresanta JL, Srinivasan SR, Burke GL, Hunter SM, et al. Adverse influences of alcohol, tobacco, and oral contraceptive use on catidiovascular risk factors during transition to adulthood. Am J Epidemiol. 1987;126:202-213.
13. Srinivasan SR, Wattigney A, Webber LS, Berenson GS. Race and gender differences in serum lipoproteins of children, adolescents, and young adults-emergence of an adverse lipoprotein pattern in white males: The Bogalusa heart study. Prev Med. 1991;20:671-684.
14. Webber LS, Huntet SM, Johnson CC, Srinivasan SR, Berenson GS. Smoking, alcohol, and oral contraceptives. Effect on lipids during adolescence and young adulthood: Bogalusa Heart Study. Ann NY Acad Sci. 1991;623:135-154.
15. Wahl P, Walden C, Knopp R, Hoover J, Wallace R, Heiss G, et al. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. New Eng J Med. 1983;308:862-867.
16. Berenson GS, McMahan CA, Voors AW, Webber LS, Srinivasan SR, Frank GC, et al. Cardiovascular Risk Factors in Children: The Early Natural History of Atherosclerosis and Essential Hypertension. New York: Oxford University Press; 1980.
17. Lipid Research Clinics. Lipid Research Clinics Program Manual of Laboratory Operations, v.1. Bethesda, MD: National Institutes of Health, DHEW Publication NO. (NIH)75-628, 1974.
18. Srinivasan SR, Berenson GS. Serum lipoprotein in children and methods for study. In: Lewis LA, ed. CRC Handbook of Electrophoresis. v.3: Lipoprotein Methodology and Human Studies. Boca Raton: CRC; 1983:185-206.
19. National Cholesterol Education Program. Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). National Heart, Lung and Blood Institute. NIH Publication No. 93-3095;1993.
20. Henzl MR. Contraceptive hormones and their clinical use. In: Yen SS, Jaffe RD, eds. Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management. Philadelphia: W. B. Saunders; 1991:807-829.
21. Gerstman BB, Gross TP, Kennedy DL, Bennett RC, Tomita DK, Stadel BV. Trends in the content and use of oral contraceptives in the United States, 1964-88. Am J Public Health. 1991;81:90-98.
22. Rosner B. The analysis of longitudinal data in epidemiologic studies. J Chronic Dis. 1979;32:163-173.
23. Hennekens CH, Evans DA, Castelli WP, Taylor JO, Rosner B, Kass EH. Oral contraceptive use and fasting triglyceride, plasma cholesterol and HDL cholesterol. Circulation. 1979;60:486-489.
24. Piper JM, Kennedy DL. Oral contraceptives in the United States: Trends in content and potency. Int J Epidemiol. 1987;16:215-221.
25. Barrett DH, Anda RF, Escobedo LG, Croft JB, Williamson DF, Marks JS. Trends in oral contraceptive use and cigarette smoking. Arch Fam Med. 1994;3:438-443.
26. Goldbaum GM, Kendrick JS, Hogelin GC, Gentry EM. The relative impact of smoking and oral contraceptive use on women in the United States. JAMA. 1987;258:1339-1342.
27. Rosenberg L. Kaufman DW, Helmrich SP, Miller DR, Stolley PD, Shapiro S. Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA. 1985;253:2965-2969.